The diagnosis of service-related occupational diseases has undergone a dramatic shake-up over the last decades. While it used to be all about simple clinical observation and symptoms, it’s now a full-blown scientific discipline involving advanced imaging, molecular analysis, and what not.
For a researcher in occupational health, keeping up with this technological revolution in service-related diagnoses is vital, especially when considering exposure circumstances where decades can go by following first exposure to a substance before you notice any signs of malignancy. Here’s more about medical advancements that have completely changed how clinicians and researchers identify causality in occupational environments and subsequent health outcomes.
High-Resolution Computed Tomography and Pleural Imaging
HRCT or high-resolution computed tomography scanning is quickly changing the way we detect pleural and lung pathology due to exposure in occupational settings. While conventional chest X-rays may not detect early changes, HRCT can detect very small, subtle changes in the lungs with incredible sensitivity, making it easier to identify pleural thickening, pleural plaques, and parenchymal opacities indicating chronic occupational lung diseases.
The medical utility of HRCT scans extends beyond simply pointing out features in an image. HRCT scans allow occupational health scientists to classify and assess the severity of a case using standardized protocols. This enables them to identify a dose-response relationship between exposure intensity and lung damage. This is particularly important when researching illnesses stemming from exposure to fibrous materials such as asbestos in army barracks.
Soldiers serving on bases built with materials containing asbestos have often been exposed to microscopic fibers that can cause damage over time. HRCT scans can help identify these changes and reveal characteristic pleural plaques and thickening in servicemen exposed to significant asbestos fibers. The technology provides irrevocable proof concerning exposure to these harmful materials on the job.
This imaging technology has also made it possible to have concrete visual documentation of disease progression. It puts scientists and clinicians in a better position to diagnose asbestosis, mesothelioma, and other pleural-based occupational diseases years earlier than was previously possible. In fact, HRCT scanning goes a long way in identifying anatomical changes early, fueling future research to improve everything.
What it means is that occupational epidemiologists can now detect a definite progression in diseases over time and check if exposure on military bases matches a corresponding shift in the structure of lungs. This marks a major shift away from the previous trend of relying solely on symptoms for diagnosis.
Biomarker Analysis and Molecular Diagnostics
The emerging field of molecular pathology incorporates a new set of diagnostic tools based on markers that can identify occupational diseases at the cellular level, in some cases even before you can detect radiological changes.
The goal is to measure blood markers associated with mesothelioma. Some of these markers are mesothelin, fibulin-3, and other proteins associated with this form of cancer. With molecular diagnostics, it’s possible to measure these markers through a blood test, which provides a noninvasive glimpse into exactly how this occupational disease develops.
The relevance of biomarker diagnostics helps address a large practical problem in occupational medicine that’s about establishing causality in a patient with latent disease. A patient with many years of military service developing mesothelioma will want proof that their years of exposure caused them to become ill, and this causality can be established with solid, irrefutable evidence connecting exposure to progression using rising levels of biomarkers.
Endnote
These diagnostic achievements represent modernization in diagnosing occupational diseases. Together, these technologies allow for earlier disease detection, better substantiation of causal associations, and, most importantly, increased access to benefits and treatment associated with occupational diseases arising from military service.
